Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25565816 | 0.92 | PRKCA (0.33) | PRKCA | |
| SCHEMBL12938546 | 0.87 | MAPK1 (0.39) | PRKCAALDH1A1TP53CYP3A4MAPK1 | |
| SCHEMBL10030763 | 0.83 | MAPK1 (0.36) | PRKCAALDH1A1TP53CYP3A4MAPK1 | |
| SCHEMBL11967441 | 0.81 | MAPK1 (0.35) | PRKCAALDH1A1TP53CYP3A4MAPK1 | |
| SCHEMBL26974017 | 0.81 | MAPK1 (0.35) | PRKCAALDH1A1TP53CYP3A4MAPK1 | |
| SCHEMBL25566867 | 0.81 | — | — | |
| SCHEMBL30634536 | 0.81 | ALDH1A1 (0.42) | PRKCAALDH1A1TP53CYP3A4MAPK1 | |
| SCHEMBL13714627 | 0.77 | THRB (0.37) | PRKCAALDH1A1TP53CYP3A4MAPK1 | |
| SCHEMBL9305447 | 0.77 | PRKCA (0.40) | PRKCA | |
| SCHEMBL12938597 | 0.76 | PRKCA (0.33) | PRKCAALDH1A1TP53CYP3A4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230149562-A1 | CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY | TIBA BIOTECH LLC (US) | 2023-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230149562-A1 | CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY | POLN, TLR9, TSG101 | PRKCA 1845/4885ALDH1A1 3979/4885TP53 156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.